This disclosure relates to medical instruments, and more particularly, systems and devices for aneurysm therapy.
Aneurysms can be complicated and difficult to treat. For example, treatment access may be limited or unavailable when an aneurysm is located proximate critical tissues. Such factors are of particular concern with cranial aneurysms due to the brain tissue surrounding cranial vessels the corresponding limited treatment access.
Prior solutions have included endovascular treatment access whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. In this respect, because the interior walls of the aneurysm may continue being subjected to flow of blood and related pressure, aneurysm rupture remains possible.
Alternative to endovascular or other surgical approaches can include occlusive devices. Such devices have typically incorporated multiple embolic coils that are delivered to the vasculature using microcatheter delivery systems. For example, when treating cranial aneurysms, a delivery catheter with embolic coils is typically first inserted into non-cranial vasculature through a femoral artery in the hip or groin area. Thereafter, the catheter is guided to a location of interest within the cranium. The sac of the aneurysm can then be filled with the embolic material to create a thrombotic mass that protects the arterial walls from blood flow and related pressure. However, such occlusive devices do have certain shortcomings, including mass effect, which can cause compression on the brain and its nerves.
One particular type of occlusive approach endeavors to deliver and treat the entrance or “neck” of the aneurysm as opposed to the volume of the aneurysm. In such “neck” approaches, by minimizing blood flow across the neck, then a cessation of flow into the aneurysm may be achieved. In turn, a thrombotic mass may naturally form without having to deliver embolic materials, as previously described. This is preferable to masses formed from embolic material since a natural mass can improve healing by reducing possible distention from arterial walls and permits reintegration into the original parent vessel shape along the neck plane of the aneurysm. It is understood that the neck plane is an imaginary surface where the inner most layer of the parent wall would be but for the aneurysm. However, neck-occlusive approaches are not without drawbacks. It is desired to block the neck of the aneurysm in the parent vessel. Furthermore, embolic coils do not always effectively treat aneurysms as re-canalization of the aneurysm and/or coil compaction can occur over time.
It is therefore desirable to have a device which easily, accurately, and safely occludes a neck of an aneurysm or other arterio-venous malformation in a parent vessel without blocking flow into perforator vessels communicating with the parent vessel.
In some embodiments, the present disclosure relates to a braid for treating an aneurysm. The braid can include a first radially expandable segment operable to move from a collapsed state within a microcatheter to a deployed state distal of the microcatheter. The first radially expandable segment can be capable of radially expanding to form an outer occlusive sack in the aneurysm that seals the neck of the aneurysm in the deployed state. The braid can also include a second radially expandable segment operable to move from the collapsed state within the microcatheter to the deployed state distal of the microcatheter, wherein the second radially expandable segment is capable of radially expanding inside the outer occlusive sack to form an inner occlusive sack in the outer occlusive sack in the deployed state. An expansion mechanism can be included and be disposed at a proximal end of the first and second radially expandable segments.
In some embodiments, the expansion mechanism can include an expansion ring with an opening. A distal end of the braid can be inserted through the opening and then the proximal end can be folded over the opening.
In some embodiments, the expansion mechanism can include an opening and a plurality of radially flexible elements. Each flexible element can be capable of expanding from a collapsed condition in the microcatheter to an expanded condition in the deployed state distal of the microcatheter to support a proximal portion of the outer occlusive sack. Each radially flexible element can be evenly radially spaced about a central axis of the expansion mechanism. The central axis of the expansion mechanism can be axially aligned with a central axis of the first and second radially expandable segments.
In some embodiments, the expansion mechanism can include at least four radially spaced flexible elements that extend from an expansion ring (e.g. a radially movable leaf capable of moving between collapsed to deployed conditions). However, the solution is not so limited any instead greater or fewer than four leaves can be included, as needed or required.
In some embodiments, the expansion ring and leaf or leaves can be a monolithic structure. The expansion ring and leaf or leaves can also be formed from a memory alloy material such as nitinol.
In some embodiments, the expansion mechanism can include a plurality of expandable support elements that include potential energy stored in the collapsed state (e.g. the support elements may include biased bias elements or be memory shaped to expand a predetermined manner and release a predetermined amount of potential energy). The expandable support elements can be configured to urge the proximal end of the first radially expandable segment from the collapsed to the deployed state by releasing the potential energy of the expandable support elements.
In some embodiments, a porosity of the inner occlusive sack is greater than a porosity of the outer occlusive sack.
In some embodiments, distally translating the braid after the outer occlusive sack is formed causes an inner layer of the braid inside of the outer occlusive sack to radially expand inside the outer occlusive sack and form the inner occlusive sack. The inner layer of the braid can also be capable of radially expanding inside the outer occlusive sack while the outer occlusive sack is pushed against the aneurysm wall and aneurysm neck.
In some embodiments, a marker band can be included and in communication with the proximal end of the braid. The inner layer that radially expands inside the outer occlusive sack can also be formed by folding the proximal end over the marker band.
In some embodiments, wherein in the deployed state, the braid is detachable from a delivery system in the aneurysm.
In some embodiments, the delivery system can include a microcatheter and a delivery tube. The distal end of the delivery tube can be detachably connected to the proximal end of the braid. The delivery tube can be translatably disposable within the microcatheter. The delivery tube can also be capable of distally translating the braid within the microcatheter from the collapsed state to the deployed state.
In some embodiments, the outer occlusive sack can be a collapsible cage-like vaso-occlusive structure.
In some embodiments, the outer occlusive sack can include fewer wire segments than the inner occlusive sack.
In some embodiments, dimensions of interstices of the braid vary at the proximal end versus the distal end so that a porosity of the outer occlusive sack is less than a porosity of the inner occlusive sack.
In some embodiments, the braid can be included in a system or otherwise in communication with an imaging device capable of imaging the outer and/or inner occlusive sacks with respect to the aneurysm. An orientation of the outer and/or inner occlusive sacks can be adjustable by the braid being distally or proximally moved.
In some embodiments, an occlusive device for treating an aneurysm is provided. The device can include a braid being translatably disposable within a microcatheter from a collapsed state to a deployed state. The braid can include a distal end and a proximal end. In the deployed state, the braid can include an outer occlusive sack capable of pushing against an aneurysm wall of the aneurysm and sealing a neck of the aneurysm to deflect, divert, and/or slow a flow into the aneurysm, an inner occlusive sack disposed inside the outer occlusive sack, and an expansion mechanism disposed at the proximal end for urging formation of the outer and/or inner occlusive sacks in the deployed state.
In other embodiments, a method of occluding an aneurysm is disclosed. The method can include one or more of the following steps: positioning a radially expandable braid within a microcatheter, the braid being in a collapsed state within the microcatheter and comprising a distal end and a proximal end; attaching the proximal end of the braid to the distal end of a delivery tube; distally sliding the braid from the microcatheter, by the delivery tube, towards an aneurysm; urging a first radially expandable segment of the braid to form an outer occlusive sack by expanding an expansion mechanism of the braid, wherein the expansion mechanism is attached to the proximal end of the braid; laying the outer occlusive sack across a neck of the aneurysm; and further distally pushing the braid thereby expanding a second radially expandable segment inside of the outer occlusive sack while distally pushing the outer occlusive sack against the aneurysm wall and the neck of the aneurysm.
In certain embodiments, the method can include releasing the braid, including the outer and inner occlusive sacks, and withdrawing the delivery tube and the microcatheter from the aneurysm.
In certain embodiments, the expansion mechanism includes a plurality of radially spaced flexible elements, each flexible element capable of expanding from a collapsed condition in the microcatheter to an expanded condition in the deployed state to support a proximal portion of the outer occlusive sack. In this respect, the method can also include axially aligning the central axis of the expansion mechanism with a central axis of the first and second radially expandable segments; and radially spacing each flexible element about the central axis of the expansion mechanism.
In some embodiments, the method can include providing an expansion ring with an opening on or with the expansion mechanism; inserting a distal end of the braid through the opening; and folding the proximal end of the braid over the opening.
In some embodiments, the method can include radially spacing, about the expansion mechanism, at least four flexible elements that extend from an expansion ring, each flexible element being a radially movable leaf capable of moving between collapsed to deployed conditions.
In some embodiments, the method can include forming a monolithic structure from the expansion ring and the at least four flexible elements.
In some embodiments, the method can include forming a plurality of expandable support elements on the expansion mechanism that comprise potential energy stored in the collapsed state; and urging, by the expandable support elements, the proximal end of the first radially expandable segment from the collapsed to the deployed state by releasing the potential energy.
In some embodiments, the method can include forming the first radially expandable segment with a porosity lower than a porosity of the second radially expandable segment; positioning the first radially expandable segment adjacent or in communication with a neck of the aneurysm; and deflecting, diverting, and/or slowing a flow into the aneurysm.
Other aspects and features of the present disclosure will become apparent to those of ordinary skill in the art, upon reviewing the following detailed description in conjunction with the accompanying figures.
Reference will now be made to the accompanying drawings, which are not necessarily drawn to scale.
Although example embodiments of the disclosed technology are explained in detail herein, it is to be understood that other embodiments are contemplated. Accordingly, it is not intended that the disclosed technology be limited in its scope to the details of construction and arrangement of components set forth in the following description or illustrated in the drawings. The disclosed technology is capable of other embodiments and of being practiced or carried out in various ways.
It must also be noted that, as used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. By “comprising” or “containing” or “including” it is meant that at least the named compound, element, particle, or method step is present in the composition or article or method, but does not exclude the presence of other compounds, materials, particles, method steps, even if the other such compounds, material, particles, method steps have the same function as what is named.
In describing example embodiments, terminology will be resorted to for the sake of clarity. It is intended that each term contemplates its broadest meaning as understood by those skilled in the art and includes all technical equivalents that operate in a similar manner to accomplish a similar purpose. It is also to be understood that the mention of one or more steps of a method does not preclude the presence of additional method steps or intervening method steps between those steps expressly identified. Steps of a method may be performed in a different order than those described herein without departing from the scope of the disclosed technology. Similarly, it is also to be understood that the mention of one or more components in a device or system does not preclude the presence of additional components or intervening components between those components expressly identified.
As discussed herein, vasculature can be that of any “subject” or “patient” including of any human or animal. It should be appreciated that an animal may be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal may be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like). It should be appreciated that the subject may be any applicable human patient, for example.
As discussed herein, “operator” may include a doctor, surgeon, or any other individual or delivery instrumentation associated with delivery of a braid body to the vasculature of a subject.
Relatedly, flow diverters that are deployed across the aneurysm neck can alter the flow of blood into the aneurysm. An example flow diverter can be a braided device with relatively low porosity. Over time, the aneurysms can heal by sealing the aneurysm neck with a high rate of success. However, flow diversion technology is not without limitations. Challenges include placement of the devices intra-vascularly due to vessel morphology, vessel tortuosity, or braid malposition. In addition, patients receiving a flow diverter must be on anticoagulation medicine for an extended period to prevent vessel thrombosis. Intravascular devices also aim to cut circulation into the aneurysm while minimizing the amount of metal in the vessel and significantly cutting, or eliminating the need for coagulation medication. These types of devices may also be easier to track and/or deploy at the lesion site.
The occlusive device 1 disclosed herein addresses these and other drawbacks of previous approaches by using a single device to seal the aneurysm neck. Turning to
An expansion mechanism 9 can also be included disposed at or about proximal end 16 of braid 10. The expansion mechanism 9 can include one or more flexible support elements 7 that extend from or are attached to an expansion ring 5 with an opening 3. As shown, the flexible support elements 7 can be oriented to extend along the inner layer of braid 10 in both the collapsed and deployed states. Each flexible support element 7 of mechanism 9 can be elongate and extend at one or more depths into braid 10. Each element 7 of mechanism 9 can facilitate expansion of braid 10 to form sacks of segments 12 and/or 13, collectively with other flexible elements or individually. The flexible support element 7 is also referred to interchangeably herein as an elongate support element 7, a support element 7, or a flexible element 7.
The mesh of braid 10 can be defined by one or more mesh patterns, one or more discrete mesh portions, and/or one or more mesh openings defined by braided filaments. For example, the mesh of braid 10 can include a porosity region associated with an outer occlusive sack formed by braid 10 and another porosity region associated with an inner occlusive sack configured to expand and/or internally overlay the outer occlusive sack. The inner occlusive sack can have a higher porosity than the outer occlusive sack. For example, the mesh of braid 10 shown in
Each of segments 12, 13 can be radially expandable and capable of being disposed inside microcatheter 20 in a collapsed state. Segment 12 can be an expandable, outer shell while segment 13 can be an inner, expandable shell. Segment 12 may expand and only partially file some of the aneurysm as shown and may form a “cup” like shape that within segment 13 can form and expand. Each of segments 12, 13 can be heat shaped to spherical, saddled, ellipsoid shaped, or any other shape, as shown in
In practice, the porosity of segment 12 can permit the outer occlusive sack of segment 12 to take on many shapes prior to, during, or after delivery to aneurysm A. For example, the porosity of segment 12 can be relatively low to permit its sack to flexibly conform to a plurality of different shaped aneurysms. Segment 12 in this respect can have a porosity less than the porosity of segment 13 based on differing aperture sizes of the mesh. The porosities associated with segments 12, 13 and/or any other region or segment of braid 10 can also include a mesh with filaments having a different shape and/or pick count than the filaments in the other porosity regions.
The mesh of braid 10 can be comprised of a tube that is closed at one end (e.g. proximal end 16) and/or opened at opposite distal ends 14 and 18. Braid 10 can be made of several materials such as deposited thin films or of one single material. The mesh of braid 10 can include multiple wires, for example from 4 to 96 wires. The number of wires can be a factor in controlling material properties of the braid 10, including the porosity, shape in the deployed state, flexibility, stiffness, and the like. The combination of the one or more sacks internally overlaid with an outer occlusive sack can be considered when determining the number of wires of the mesh of braid 10 since one sack is inside the other. Further, the outer occlusive sack of segment 12 and/or the inner occlusive sack of segment 13 can be a collapsible cage-like vaso-occlusive structure.
The diameter of the braid 10, and the braid wire count can vary depending the diameter of the device needed to treat the aneurysm, and/or the desired porosity. For example, the distal end 14 of segment 12 can be an open end with a first diameter. The distal end 18 of segment 13 can be an open end with a second diameter that is less than the first diameter in the deployed state. The braid angle of the braid 10 can also be fixed, or vary along the length of braid 10 to create different porosity therealong. For example, to induce formation of the predetermined shape and strength of the occlusive sacks of segments 12 and 13, ends 14 and 18 may be more pliable than end 16, or vice versa, and other segments of braid 10 may vary from most pliable on or about end 14 and/or end 18 and less pliable on or about end 16. In some embodiments, ends 14, 18 can be looped as shown, which is particularly advantageous to ensure that the braid 10 is atraumatic when in contact with the dome of aneurysm A.
The number of wires, braid angle, patterns, or the like, can be used to define the porosities of segments 12, 13. The wires of braid 10 can be made from nitinol with interwoven platinum filaments for radiopacity, or Drawn Filled Tube (DFT) Nitinol with 10 to 40% Platinum. The wires can be made from a nickel-titanium alloy, cobalt chromium alloys, Stainless Steel, Tantalum, and/or other alloys, and/or any other suitable biocompatible materials, or combination of these materials. Also, these materials can be absorbable or non-absorbable by the patient over time. In this respect, the first porosity associated with segment 12 can be less than the second porosity associated with segment 13. Arranging segments 12, 13 in the deployed state, varying the braid properties, and/or positioning segment 12 adjacent or in communication with a neck of the aneurysm can induce a flow diverting effect. Material properties of segments 12, 13 can differ in other respects as well, as needed or required, including heat treatment or covering.
The apertures in the mesh of braid 10 can also create a substantially unitary frame work or mesh. Thus, the apertures may be of any size, shape, or porosity, and may be uniformly or randomly spaced throughout the wall of the mesh of braid 10. The apertures can provide the tubular element of braid 10 with flexibility and also assist in the transformation of the mesh from the collapsed state to the expanded, deployed state, and vice versa.
As shown in
Delivery tube 30 can be substantially elongate and can extend from the proximal 26 to the distal end 24 of microcatheter 20. Tube 30 can generally run along the inner lumen of microcatheter 20 and may leave a space between its outer surface and the internal surface of microcatheter 20. In turn, delivery tube 30 and microcatheter 30 may be axially aligned. System 40 can deliver braid 10 to a location of interest (e.g. a lesion site) using microcatheter 20. In certain embodiments, microcatheter 20 can be pre-placed at a level of the aneurysm neck and used to track the device 1 to the lesion, for example by tracking marker band 44 that can have radiopaque material. Delivery tube 30 can be in mechanical connection with braid 10 at locking portion 54. As shown more particularly below, locking portion 54 can comprise or be a pusher ring. Braid 10 may be attached to locking portion 54 by slidable attachment, permanent attachment (e.g. crimped, laser, ultrasonic weld, or other sources of heat, adhesive, or the like) or other attachment approaches. When delivery tube 30 is mechanically attached to braid 10 at locking portion 54, distally translating, sliding, or otherwise moving tube 30 towards the aneurysm A can cause braid 10 to begin moving from the collapsed state within microcatheter 20 to its deployed state external to microcatheter 20 with segments 12 and 13.
In the deployed state, some or all of braid 10 is distal of microcatheter 20 so that segments 12, 13 can radially expand. Braid 10 is particularly advantageous as it is capable of being collapsed within microcatheter 20 and also can form multiple occlusive sacks in the deployed state. The mesh of braid 10 can be configured with or without mechanism 9 so that as braid 10 is distally translated and its end 14 exits from within microcatheter 20, mechanism 9 can urge segment 12 to radially expand to form an outer occlusive sack of the first porosity. The outer occlusive sack of segment 12 can be formed as portions of flexible support elements 7 of mechanism 9 are distal of end 24 and end 14 of braid 10 slides away from end 24 of microcatheter 20. When flexible support elements 7 of mechanism 9 are no longer contained completely within microcatheter 20, they can then release potential energy stored therein and facilitate formation of the occlusive sacks of segments 12 and/or 13.
As braid 10 is further distally translated, segment 13 can begin to radially expand internal to the outer occlusive sack of segment 12. By radially expanding inside segment 12, segment 13 can form an inner occlusive sack with a porosity greater than the porosity of segment 12. As shown in
In certain embodiments, the expansion mechanism 9 can include at least four radially spaced flexible support elements 7 that extend from a central portion of mechanism 9, such as expansion ring 5. When collapsed, the expansion mechanism 9 can be sized to fit through the neck of the aneurysm. When expanded and delivered to the aneurysm, the expansion mechanism 9 can be larger and block the neck. As shown in
As shown in
In practice, as shown in
Turning to
As shown in the transitional state of
In
Braid 10 can include a pre-weakened or transition portion 19 (e.g., depicted in
In
As also seen moving between
Once expanded and positioned, delivery tube 30 can be proximally translated back into microcatheter 20 and retracted from the braid 10 and aneurysm A. In particular,
The compressible portion 38 can allow the delivery tube 30 to bend and/or flex. Such flexibility can assist tracking the braid 10 through the microcatheter 20 and the tortuous path through the vasculature. The compressible portion 38 can be formed with interference spiral cuts that can allow for gaps to permit bending but in one example, do not act as a spiral-cut spring. Compressible portion 38 can be axially adjustable between an elongated condition and a compressed condition. However, any other arrangement allowing axial adjustment (e.g., a wound wire or spiral ribbon) can also be suitable for use with detachment systems according to the present disclosure). The compressible portion 38 can be in the elongated condition at rest and automatically or resiliently returns to the elongated condition from a compressed condition, unless otherwise constrained. The function of the compressible portion 38 is described in greater detail herein.
A force F was previously applied to place the delivery tube 30 in a compressed state.
In certain embodiments of method 900, the expansion mechanism can include a plurality of radially spaced flexible elements, each flexible element capable of expanding from a collapsed condition in the microcatheter to an expanded condition in the deployed state to support a proximal portion of the outer occlusive sack. In this respect, the method 900 can also include axially aligning the central axis of the expansion mechanism with a central axis of the first and second radially expandable segments; and radially spacing each flexible element about the central axis of the expansion mechanism.
The method 900 can also include providing an expansion ring with an opening on or with the expansion mechanism; inserting a distal end of the braid through the opening; and folding the proximal end of the braid over the opening. The method 900 can also include radially spacing, about the expansion mechanism, at least four flexible elements that extend from an expansion ring, each flexible element being a radially movable leaf capable of moving between collapsed to deployed conditions. The method 900 can also include forming a monolithic structure from the expansion ring and the at least four flexible elements. The method 900 can also include forming a plurality of expandable support elements on the expansion mechanism that comprise potential energy stored in the collapsed state; and urging, by the expandable support elements, the proximal end of the first radially expandable segment from the collapsed to the deployed state by releasing the potential energy. The method 900 can also include forming the first radially expandable segment with a porosity lower than a porosity of the second radially expandable segment; positioning the first radially expandable segment adjacent or in communication with a neck of the aneurysm; and inducing a flow diverting effect across the neck of the aneurysm when the inner occlusive sack is formed inside the outer occlusive sack.
It is understood that variations of the braid 10 can include various materials such as stainless steel, bio absorbable materials, and polymers. Braid 10, including any specific portions such as any breaks, varying regions of differing porosities, and occlusive sacks, can be heat set to various configurations such as spherical, oblong, saddle shaped, or the like, for the purpose of shaping the outer and/or inner sack to better match the aneurysm morphology. In addition, the braid 10 can be heat shaped to include weak points to facility the radial expansion of the occlusive sacks. Further, interstices of braid 10 that form the sacks can vary, or be selectively designed, in size or shape along its length depending on how much braid 10 is caused to radially expand as delivery tube 30 is distally moved.
It is understood that the braid 10 can also be included in a system or otherwise in communication with an imaging device capable of imaging the outer and/or inner occlusive sacks of segments 12 and 13 with respect to the aneurysm. An orientation of the outer and/or inner occlusive sacks can be adjustable by the braid 10 being distally or proximally moved with respect to the aneurysm and monitored precisely by the imaging device.
The specific configurations, choice of materials and the size and shape of various elements can be varied according to particular design specifications or constraints requiring a system or method constructed according to the principles of the disclosed technology. Such changes are intended to be embraced within the scope of the disclosed technology. The presently disclosed embodiments, therefore, are considered in all respects to be illustrative and not restrictive. It will therefore be apparent from the foregoing that while particular forms of the disclosure have been illustrated and described, various modifications can be made without departing from the spirit and scope of the disclosure and all changes that come within the meaning and range of equivalents thereof are intended to be embraced therein.
The present application is a continuation application of U.S. patent application Ser. No. 15/879,196 filed Jan. 24, 2018. The entire contents of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2849002 | Oddo | Aug 1958 | A |
3480017 | Shute | Nov 1969 | A |
4085757 | Pevsner | Apr 1978 | A |
4282875 | Serbinenko et al. | Apr 1981 | A |
4364392 | Strother et al. | Dec 1982 | A |
4395806 | Wonder et al. | Aug 1983 | A |
4517979 | Pecenka | May 1985 | A |
4545367 | Tucci | Oct 1985 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4991602 | Amplatz et al. | Feb 1991 | A |
5002556 | Ishida et al. | Mar 1991 | A |
5025060 | Yabuta et al. | Jun 1991 | A |
5065772 | Cox, Jr. | Nov 1991 | A |
5067489 | Lind | Nov 1991 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5261916 | Engelson | Nov 1993 | A |
5304195 | Twyford, Jr. et al. | Apr 1994 | A |
5334210 | Gianturco | Aug 1994 | A |
5350397 | Palermo | Sep 1994 | A |
5423829 | Pham et al. | Jun 1995 | A |
5624449 | Pham et al. | Apr 1997 | A |
5645558 | Horton | Jul 1997 | A |
5733294 | Forber et al. | Mar 1998 | A |
5916235 | Guglielmi | Jun 1999 | A |
5891128 | Chin et al. | Jul 1999 | A |
5928260 | Chin et al. | Jul 1999 | A |
5935148 | Villar | Aug 1999 | A |
5941249 | Maynard | Aug 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5964797 | Ho | Oct 1999 | A |
6007573 | Wallace et al. | Dec 1999 | A |
6024756 | Pham | Feb 2000 | A |
6036720 | Abrams | Mar 2000 | A |
6063070 | Eder | May 2000 | A |
6063100 | Diaz et al. | May 2000 | A |
6063104 | Villar | May 2000 | A |
6080191 | Thaler | Jun 2000 | A |
6086577 | Ken et al. | Jul 2000 | A |
6096021 | Helm et al. | Aug 2000 | A |
6113609 | Adams | Sep 2000 | A |
6123714 | Gia et al. | Sep 2000 | A |
6168615 | Ken | Jan 2001 | B1 |
6168622 | Mazzocchi | Jan 2001 | B1 |
6193708 | Ken et al. | Feb 2001 | B1 |
6221086 | Forber | Apr 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6315787 | Tsugita et al. | Nov 2001 | B1 |
6331184 | Abrams | Dec 2001 | B1 |
6334048 | Edvardsson et al. | Dec 2001 | B1 |
6346117 | Greenhalgh | Feb 2002 | B1 |
6350270 | Roue | Feb 2002 | B1 |
6375606 | Garbaldi et al. | Apr 2002 | B1 |
6375668 | Gifford | Apr 2002 | B1 |
6379329 | Naglreiter et al. | Apr 2002 | B1 |
6391037 | Greenhalgh | May 2002 | B1 |
6419686 | McLeod et al. | Jul 2002 | B1 |
6428558 | Jones | Aug 2002 | B1 |
6454780 | Wallace | Sep 2002 | B1 |
6463317 | Kucharczyk et al. | Oct 2002 | B1 |
6506204 | Mazzocchi et al. | Jan 2003 | B2 |
6527919 | Roth | Mar 2003 | B1 |
6547804 | Porter et al. | Apr 2003 | B2 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6569179 | Teoh | May 2003 | B2 |
6569190 | Whalen, II et al. | May 2003 | B2 |
6572628 | Dominguez | Jun 2003 | B2 |
6589230 | Gia et al. | Jul 2003 | B2 |
6589256 | Forber | Jul 2003 | B2 |
6605102 | Mazzocchi et al. | Aug 2003 | B1 |
6620152 | Guglielmi | Sep 2003 | B2 |
6669719 | Wallace et al. | Dec 2003 | B2 |
6689159 | Lau et al. | Feb 2004 | B2 |
6746468 | Sepetka | Jun 2004 | B1 |
6780196 | Chin et al. | Aug 2004 | B2 |
6802851 | Jones | Oct 2004 | B2 |
6811560 | Jones | Nov 2004 | B2 |
6833003 | Jones et al. | Dec 2004 | B2 |
6846316 | Abrams | Jan 2005 | B2 |
6849081 | Sepetka et al. | Feb 2005 | B2 |
6855154 | Abdel-Gawwad | Feb 2005 | B2 |
6949116 | Solymar et al. | Sep 2005 | B2 |
6964657 | Cragg et al. | Nov 2005 | B2 |
6964671 | Cheng | Nov 2005 | B2 |
6994711 | Hieshima et al. | Feb 2006 | B2 |
7044134 | Khairkhahan et al. | May 2006 | B2 |
7083632 | Avellanet | Aug 2006 | B2 |
7093527 | Rapaport et al. | Aug 2006 | B2 |
7128736 | Abrams et al. | Oct 2006 | B1 |
7152605 | Khairkhahan et al. | Dec 2006 | B2 |
7153323 | Teoh | Dec 2006 | B1 |
7195636 | Avellanet et al. | Mar 2007 | B2 |
7229454 | Tran et al. | Jun 2007 | B2 |
7229461 | Chin et al. | Jun 2007 | B2 |
7309345 | Wallace | Dec 2007 | B2 |
7371249 | Douk et al. | May 2008 | B2 |
7377932 | Mitelberg et al. | May 2008 | B2 |
7410482 | Murphy et al. | Aug 2008 | B2 |
7572288 | Cox | Aug 2009 | B2 |
7597704 | Frazier et al. | Oct 2009 | B2 |
7608088 | Jones | Oct 2009 | B2 |
7695488 | Berenstein et al. | Apr 2010 | B2 |
7713264 | Murphy | May 2010 | B2 |
7744652 | Morsi | Jun 2010 | B2 |
7892248 | Tran | Feb 2011 | B2 |
7985238 | Balgobin et al. | Jul 2011 | B2 |
RE42758 | Ken | Sep 2011 | E |
8016852 | Ho | Sep 2011 | B2 |
8021416 | Abrams | Sep 2011 | B2 |
8025668 | McCartney | Sep 2011 | B2 |
8034061 | Amplatz et al. | Oct 2011 | B2 |
8048145 | Evans et al. | Nov 2011 | B2 |
8062325 | Mitelberg et al. | Nov 2011 | B2 |
8075585 | Lee et al. | Dec 2011 | B2 |
8142456 | Rosqueta et al. | Mar 2012 | B2 |
8221483 | Ford et al. | Jul 2012 | B2 |
8261648 | Marchand et al. | Sep 2012 | B1 |
8267923 | Murphy | Sep 2012 | B2 |
8361106 | Solar et al. | Jan 2013 | B2 |
8361138 | Adams | Jan 2013 | B2 |
8372114 | Hines | Feb 2013 | B2 |
8398671 | Chen | Mar 2013 | B2 |
8430012 | Marchand | Apr 2013 | B1 |
8454633 | Amplatz et al. | Jun 2013 | B2 |
8523897 | van der Burg et al. | Sep 2013 | B2 |
8523902 | Heaven et al. | Sep 2013 | B2 |
8551132 | Eskridge et al. | Oct 2013 | B2 |
8777974 | Amplatz et al. | Jul 2014 | B2 |
8900304 | Alobaid | Dec 2014 | B1 |
8974512 | Aboytes et al. | Mar 2015 | B2 |
8992568 | Duggal et al. | Mar 2015 | B2 |
8998947 | Aboytes et al. | Apr 2015 | B2 |
9055948 | Jaeger et al. | Jun 2015 | B2 |
9107670 | Hannes et al. | Aug 2015 | B2 |
9161758 | Figulla et al. | Oct 2015 | B2 |
9232992 | Heidner et al. | Jan 2016 | B2 |
9259337 | Cox et al. | Feb 2016 | B2 |
9314326 | Wallace et al. | Apr 2016 | B2 |
9351715 | Mach | May 2016 | B2 |
9414842 | Glimsdale et al. | Aug 2016 | B2 |
9526813 | Cohn et al. | Dec 2016 | B2 |
9532792 | Galdonik et al. | Jan 2017 | B2 |
9532873 | Kelley | Jan 2017 | B2 |
9533344 | Monetti et al. | Jan 2017 | B2 |
9539011 | Chen et al. | Jan 2017 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9539122 | Bowman | Jan 2017 | B2 |
9539382 | Nelson | Jan 2017 | B2 |
9549830 | Bruszewski et al. | Jan 2017 | B2 |
9554805 | Tompkins et al. | Jan 2017 | B2 |
9561096 | Kim et al. | Feb 2017 | B2 |
9561125 | Bowman et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9579104 | Beckham et al. | Feb 2017 | B2 |
9579484 | Barnell | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9585669 | Becking et al. | Mar 2017 | B2 |
9615832 | Bose et al. | Apr 2017 | B2 |
9615951 | Bennett et al. | Apr 2017 | B2 |
9622753 | Cox | Apr 2017 | B2 |
9629635 | Hewitt et al. | Apr 2017 | B2 |
9636115 | Henry et al. | May 2017 | B2 |
9636439 | Chu et al. | May 2017 | B2 |
9642675 | Werneth et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9655645 | Staunton | May 2017 | B2 |
9655989 | Cruise et al. | May 2017 | B2 |
9662129 | Galdonik et al. | May 2017 | B2 |
9662238 | Dwork et al. | May 2017 | B2 |
9662425 | Lilja et al. | May 2017 | B2 |
9668898 | Wong | Jun 2017 | B2 |
9675477 | Thompson | Jun 2017 | B2 |
9675782 | Connolly | Jun 2017 | B2 |
9676022 | Ensign et al. | Jun 2017 | B2 |
9681861 | Heisei et al. | Jun 2017 | B2 |
9692557 | Murphy | Jun 2017 | B2 |
9693852 | Lam et al. | Jul 2017 | B2 |
9700262 | Janik et al. | Jul 2017 | B2 |
9700399 | Acosta-Acevedo | Jul 2017 | B2 |
9717421 | Griswold et al. | Aug 2017 | B2 |
9717500 | Tieu et al. | Aug 2017 | B2 |
9717502 | Teoh et al. | Aug 2017 | B2 |
9724103 | Cruise et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9750565 | Bloom et al. | Sep 2017 | B2 |
9757260 | Greenan | Sep 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9770251 | Bowman et al. | Sep 2017 | B2 |
9770577 | Li et al. | Sep 2017 | B2 |
9775621 | Tompkins et al. | Oct 2017 | B2 |
9775706 | Peterson et al. | Oct 2017 | B2 |
9775732 | Khenansho | Oct 2017 | B2 |
9788800 | Mayoras, Jr. | Oct 2017 | B2 |
9795391 | Saatchi et al. | Oct 2017 | B2 |
9801980 | Karino et al. | Oct 2017 | B2 |
9808599 | Bowman et al. | Nov 2017 | B2 |
9826980 | Figulla et al. | Nov 2017 | B2 |
9833252 | Sepetka et al. | Dec 2017 | B2 |
9833604 | Lam et al. | Dec 2017 | B2 |
9833625 | Waldhauser et al. | Dec 2017 | B2 |
9918720 | Marchand et al. | Mar 2018 | B2 |
9955976 | Hewitt et al. | May 2018 | B2 |
10004510 | Gerberding | Jun 2018 | B2 |
10130372 | Griffin | Nov 2018 | B2 |
10307148 | Heisel et al. | Jun 2019 | B2 |
10327781 | Divino et al. | Jun 2019 | B2 |
10342546 | Sepetka et al. | Jul 2019 | B2 |
10517604 | Bowman et al. | Dec 2019 | B2 |
10653425 | Gorochow et al. | May 2020 | B1 |
10716573 | Connor | Jul 2020 | B2 |
10743884 | Lorenzo | Aug 2020 | B2 |
10751066 | Lorenzo | Aug 2020 | B2 |
10905430 | Lorenzo | Feb 2021 | B2 |
11464518 | Connor | Oct 2022 | B2 |
20020068974 | Kuslich et al. | Jun 2002 | A1 |
20020082638 | Porter et al. | Jun 2002 | A1 |
20020143349 | Gifford, III et al. | Oct 2002 | A1 |
20020147497 | Belef et al. | Oct 2002 | A1 |
20020188314 | Anderson et al. | Dec 2002 | A1 |
20030028209 | Teoh et al. | Feb 2003 | A1 |
20030120337 | Van Tassel et al. | Jun 2003 | A1 |
20030171739 | Murphy et al. | Sep 2003 | A1 |
20030176884 | Berrada et al. | Sep 2003 | A1 |
20030181927 | Wallace | Sep 2003 | A1 |
20030181945 | Opolski | Sep 2003 | A1 |
20030195553 | Wallace | Oct 2003 | A1 |
20030216772 | Konya | Nov 2003 | A1 |
20040034366 | van der Burg et al. | Feb 2004 | A1 |
20040034386 | Fulton et al. | Feb 2004 | A1 |
20040044391 | Porter | Mar 2004 | A1 |
20040087998 | Lee et al. | May 2004 | A1 |
20040093014 | Ho et al. | May 2004 | A1 |
20040098027 | Teoh et al. | May 2004 | A1 |
20040127935 | Van Tassel et al. | Jul 2004 | A1 |
20040133222 | Tran et al. | Jul 2004 | A1 |
20040153120 | Seifert et al. | Aug 2004 | A1 |
20040210297 | Lin et al. | Oct 2004 | A1 |
20040254594 | Alfaro | Dec 2004 | A1 |
20050021016 | Malecki et al. | Jan 2005 | A1 |
20050021072 | Wallace | Jan 2005 | A1 |
20050159771 | Petersen | Jul 2005 | A1 |
20050177103 | Hunter et al. | Aug 2005 | A1 |
20050251200 | Porter | Nov 2005 | A1 |
20060052816 | Bates et al. | Mar 2006 | A1 |
20060058735 | Lesh | Mar 2006 | A1 |
20060064151 | Guterman et al. | Mar 2006 | A1 |
20060106421 | Teoh | May 2006 | A1 |
20060155323 | Porter et al. | Jul 2006 | A1 |
20060155367 | Hines | Jul 2006 | A1 |
20060167494 | Suddaby | Jul 2006 | A1 |
20060247572 | McCartney | Nov 2006 | A1 |
20070088387 | Eskridge et al. | Apr 2007 | A1 |
20070106311 | Wallace et al. | May 2007 | A1 |
20070208376 | Meng | Jun 2007 | A1 |
20070162071 | Burkett et al. | Jul 2007 | A1 |
20070167876 | Euteneuer et al. | Jul 2007 | A1 |
20070173928 | Morsi | Jul 2007 | A1 |
20070186933 | Domingo | Aug 2007 | A1 |
20070191884 | Eskridge et al. | Aug 2007 | A1 |
20070233188 | Hunt et al. | Oct 2007 | A1 |
20070265656 | Amplatz et al. | Nov 2007 | A1 |
20070288083 | Hines | Dec 2007 | A1 |
20080097495 | Feller, III et al. | Apr 2008 | A1 |
20080103505 | Fransen | May 2008 | A1 |
20080119886 | Greenhalgh et al. | May 2008 | A1 |
20080281350 | Sepetka et al. | Nov 2008 | A1 |
20090036877 | Nardone et al. | Feb 2009 | A1 |
20090062841 | Amplatz et al. | Mar 2009 | A1 |
20090099647 | Glimsdale | Apr 2009 | A1 |
20090227983 | Griffin et al. | Sep 2009 | A1 |
20090281557 | Sander et al. | Nov 2009 | A1 |
20090287291 | Becking et al. | Nov 2009 | A1 |
20090287294 | Rosqueta et al. | Nov 2009 | A1 |
20090287297 | Cox | Nov 2009 | A1 |
20090318941 | Sepetka | Dec 2009 | A1 |
20100023046 | Heidner et al. | Jan 2010 | A1 |
20100023048 | Mach | Jan 2010 | A1 |
20100063573 | Hijlkema | Mar 2010 | A1 |
20100063582 | Rudakov | Mar 2010 | A1 |
20100069948 | Veznedaroglu et al. | Mar 2010 | A1 |
20100168781 | Berenstein | Jul 2010 | A1 |
20100211156 | Linder et al. | Aug 2010 | A1 |
20100324649 | Mattsson et al. | Dec 2010 | A1 |
20110046658 | Conner et al. | Feb 2011 | A1 |
20110054519 | Neuss | Mar 2011 | A1 |
20110112588 | Linderman et al. | May 2011 | A1 |
20110137317 | O'Halloran et al. | Jun 2011 | A1 |
20110152993 | Marchand et al. | Jun 2011 | A1 |
20110196413 | Wallace | Aug 2011 | A1 |
20110319978 | Schaffer | Dec 2011 | A1 |
20120010644 | Sideris et al. | Jan 2012 | A1 |
20120071911 | Sadasivan | Mar 2012 | A1 |
20120165732 | Müller | Jun 2012 | A1 |
20120191123 | Brister et al. | Jul 2012 | A1 |
20120283768 | Cox | Nov 2012 | A1 |
20120310270 | Murphy | Dec 2012 | A1 |
20120323267 | Ren | Dec 2012 | A1 |
20120330341 | Becking et al. | Dec 2012 | A1 |
20130035665 | Chu | Feb 2013 | A1 |
20130035712 | Theobald et al. | Feb 2013 | A1 |
20130066357 | Aboytes et al. | Mar 2013 | A1 |
20130079864 | Boden | Mar 2013 | A1 |
20130110066 | Sharma et al. | May 2013 | A1 |
20130204351 | Cox et al. | Aug 2013 | A1 |
20130211495 | Halden | Aug 2013 | A1 |
20130261658 | Lorenzo et al. | Oct 2013 | A1 |
20130261730 | Bose et al. | Oct 2013 | A1 |
20130274863 | Cox et al. | Oct 2013 | A1 |
20130345738 | Eskridge | Dec 2013 | A1 |
20140005714 | Quick et al. | Jan 2014 | A1 |
20140012307 | Franano et al. | Jan 2014 | A1 |
20140012363 | Franano et al. | Jan 2014 | A1 |
20140018838 | Franano et al. | Jan 2014 | A1 |
20140135812 | Divino et al. | May 2014 | A1 |
20140200607 | Sepetka et al. | Jul 2014 | A1 |
20140257360 | Keillor | Sep 2014 | A1 |
20140257361 | Prom | Sep 2014 | A1 |
20140277013 | Sepetka et al. | Sep 2014 | A1 |
20140358178 | Hewitt et al. | Dec 2014 | A1 |
20150057703 | Ryan et al. | Feb 2015 | A1 |
20150209050 | Aboytes et al. | Jul 2015 | A1 |
20150272589 | Lorenzo | Oct 2015 | A1 |
20150313605 | Griffin | Nov 2015 | A1 |
20150342613 | Aboytes et al. | Dec 2015 | A1 |
20150374483 | Janardhan et al. | Dec 2015 | A1 |
20160022445 | Ruvalcaba et al. | Jan 2016 | A1 |
20160030050 | Franano et al. | Feb 2016 | A1 |
20160192912 | Kassab et al. | Jul 2016 | A1 |
20160249934 | Hewitt et al. | Sep 2016 | A1 |
20160249935 | Hewitt et al. | Sep 2016 | A1 |
20170007264 | Cruise et al. | Jan 2017 | A1 |
20170007265 | Guo et al. | Jan 2017 | A1 |
20170020670 | Murray et al. | Jan 2017 | A1 |
20170020700 | Bienvenu et al. | Jan 2017 | A1 |
20170027640 | Kunis et al. | Feb 2017 | A1 |
20170027692 | Bonhoeffer et al. | Feb 2017 | A1 |
20170027725 | Argentine | Feb 2017 | A1 |
20170035436 | Morita | Feb 2017 | A1 |
20170035567 | Duffy | Feb 2017 | A1 |
20170042548 | Lam | Feb 2017 | A1 |
20170049596 | Schabert | Feb 2017 | A1 |
20170071737 | Kelley | Mar 2017 | A1 |
20170072452 | Monetti et al. | Mar 2017 | A1 |
20170079661 | Bardsley et al. | Mar 2017 | A1 |
20170079662 | Rhee | Mar 2017 | A1 |
20170079671 | Morero et al. | Mar 2017 | A1 |
20170079680 | Bowman | Mar 2017 | A1 |
20170079717 | Walsh et al. | Mar 2017 | A1 |
20170079766 | Wang et al. | Mar 2017 | A1 |
20170079767 | Leon-Yip | Mar 2017 | A1 |
20170079812 | Lam et al. | Mar 2017 | A1 |
20170079817 | Sepetka et al. | Mar 2017 | A1 |
20170079819 | Pung et al. | Mar 2017 | A1 |
20170079820 | Lam et al. | Mar 2017 | A1 |
20170086851 | Wallace et al. | Mar 2017 | A1 |
20170086996 | Peterson et al. | Mar 2017 | A1 |
20170095259 | Tompkins et al. | Apr 2017 | A1 |
20170100126 | Bowman et al. | Apr 2017 | A1 |
20170100141 | Morero et al. | Apr 2017 | A1 |
20170100143 | Granfield | Apr 2017 | A1 |
20170100183 | Iaizzo et al. | Apr 2017 | A1 |
20170113023 | Steingisser et al. | Apr 2017 | A1 |
20170114350 | dos Santos et al. | Apr 2017 | A1 |
20170147765 | Mehta | May 2017 | A1 |
20170151032 | Loisel | Jun 2017 | A1 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165065 | Rothstein et al. | Jun 2017 | A1 |
20170165454 | Tuohy et al. | Jun 2017 | A1 |
20170172581 | Bose et al. | Jun 2017 | A1 |
20170172766 | Vong et al. | Jun 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
20170189033 | Sepetka et al. | Jul 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170216484 | Cruise et al. | Aug 2017 | A1 |
20170224350 | Shimizu et al. | Aug 2017 | A1 |
20170224355 | Bowman et al. | Aug 2017 | A1 |
20170224467 | Piccagli et al. | Aug 2017 | A1 |
20170224511 | Dwork et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170231749 | Perkins et al. | Aug 2017 | A1 |
20170252064 | Staunton | Sep 2017 | A1 |
20170258473 | Plaza et al. | Sep 2017 | A1 |
20170265983 | Lam et al. | Sep 2017 | A1 |
20170281192 | Tieu et al. | Oct 2017 | A1 |
20170281331 | Perkins et al. | Oct 2017 | A1 |
20170281344 | Costello | Oct 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170281912 | Melder et al. | Oct 2017 | A1 |
20170290593 | Cruise et al. | Oct 2017 | A1 |
20170290654 | Sethna | Oct 2017 | A1 |
20170296324 | Argentine | Oct 2017 | A1 |
20170296325 | Marrocco et al. | Oct 2017 | A1 |
20170303939 | Greenhalgh et al. | Oct 2017 | A1 |
20170303942 | Greenhalgh et al. | Oct 2017 | A1 |
20170303947 | Greenhalgh et al. | Oct 2017 | A1 |
20170303948 | Wallace et al. | Oct 2017 | A1 |
20170304041 | Argentine | Oct 2017 | A1 |
20170304097 | Corwin et al. | Oct 2017 | A1 |
20170304595 | Nagasrinivasa et al. | Oct 2017 | A1 |
20170312109 | Le | Nov 2017 | A1 |
20170312484 | Shipley et al. | Nov 2017 | A1 |
20170316561 | Helm et al. | Nov 2017 | A1 |
20170319826 | Bowman et al. | Nov 2017 | A1 |
20170333228 | Orth et al. | Nov 2017 | A1 |
20170333236 | Greenan | Nov 2017 | A1 |
20170333678 | Bowman et al. | Nov 2017 | A1 |
20170340333 | Badruddin et al. | Nov 2017 | A1 |
20170340383 | Bloom et al. | Nov 2017 | A1 |
20170348014 | Wallace et al. | Dec 2017 | A1 |
20170348514 | Guyon et al. | Dec 2017 | A1 |
20180140305 | Connor | May 2018 | A1 |
20180206850 | Wang et al. | Jul 2018 | A1 |
20180242979 | Lorenzo | Aug 2018 | A1 |
20180303531 | Sanders et al. | Oct 2018 | A1 |
20180338767 | Dasnurkar et al. | Nov 2018 | A1 |
20190008522 | Lorenzo | Jan 2019 | A1 |
20190223878 | Lorenzo et al. | Jan 2019 | A1 |
20190110796 | Jayaraman | Apr 2019 | A1 |
20190142567 | Janardhan et al. | May 2019 | A1 |
20190192162 | Lorenzo | Jun 2019 | A1 |
20190192167 | Lorenzo | Jun 2019 | A1 |
20190192168 | Lorenzo | Jun 2019 | A1 |
20190223879 | Jayaraman | Jul 2019 | A1 |
20190223881 | Hewitt et al. | Sep 2019 | A1 |
20190328398 | Lorenzo | Oct 2019 | A1 |
20190357914 | Gorochow et al. | Nov 2019 | A1 |
20190365385 | Gorochow et al. | Dec 2019 | A1 |
20200000477 | Nita et al. | Jan 2020 | A1 |
20200069313 | Xu et al. | Mar 2020 | A1 |
20200268365 | Hebert et al. | Aug 2020 | A1 |
20200375606 | Lorenzo | Dec 2020 | A1 |
20210007755 | Lorenzo et al. | Jan 2021 | A1 |
20210177429 | Lorenzo | Jun 2021 | A1 |
Number | Date | Country |
---|---|---|
2395796 | Jul 2001 | CA |
2 431 594 | Sep 2002 | CA |
2598048 | May 2008 | CA |
204 683 687 | Jul 2015 | CN |
107374688 | Nov 2017 | CN |
102008015781 | Oct 2009 | DE |
102010053111 | Jun 2012 | DE |
102009058132 | Jul 2014 | DE |
10 2013 106031 | Dec 2014 | DE |
202008018523 | Apr 2015 | DE |
102011102955 | May 2018 | DE |
902704 | Mar 1999 | EP |
1054635 | Nov 2000 | EP |
1295563 | Mar 2003 | EP |
1441649 | Aug 2004 | EP |
1483009 | Dec 2004 | EP |
1527753 | May 2005 | EP |
1569565 | Sep 2005 | EP |
1574169 | Sep 2005 | EP |
1494619 | Jan 2006 | EP |
1633275 | Mar 2006 | EP |
1659988 | May 2006 | EP |
1725185 | Nov 2006 | EP |
1862122 | Dec 2007 | EP |
1923005 | May 2008 | EP |
2063791 | Jun 2009 | EP |
2134263 | Dec 2009 | EP |
2157937 | Mar 2010 | EP |
2266456 | Dec 2010 | EP |
2324775 | May 2011 | EP |
2367482 | Sep 2011 | EP |
2387951 | Nov 2011 | EP |
2460476 | Jun 2012 | EP |
2468349 | Jun 2012 | EP |
2543345 | Jan 2013 | EP |
2567663 | Mar 2013 | EP |
2617386 | Jul 2013 | EP |
2623039 | Aug 2013 | EP |
2647343 | Oct 2013 | EP |
2848211 | Mar 2015 | EP |
2854704 | Apr 2015 | EP |
2923674 | Sep 2015 | EP |
2926744 | Oct 2015 | EP |
3146916 | Mar 2017 | EP |
3501429 | Jun 2019 | EP |
3517055 | Jul 2019 | EP |
3 636 173 | Oct 2019 | EP |
H04-47415 | Apr 1992 | JP |
H07-37200 | Jul 1995 | JP |
2006-509578 | Mar 2006 | JP |
2013-509972 | Mar 2013 | JP |
2013537069 | Sep 2013 | JP |
2014-522268 | Sep 2014 | JP |
2016-502925 | Feb 2015 | JP |
WO 9641589 | Dec 1996 | WO |
WO 9905977 | Feb 1999 | WO |
WO 9908607 | Feb 1999 | WO |
WO 9930640 | Jun 1999 | WO |
WO 2003073961 | Sep 2003 | WO |
WO 03086240 | Oct 2003 | WO |
WO 2005020822 | Mar 2005 | WO |
WO 2005074814 | Aug 2005 | WO |
2005117718 | Dec 2005 | WO |
WO 2006034149 | Mar 2006 | WO |
WO 2006052322 | May 2006 | WO |
2007076480 | Jul 2007 | WO |
2008150346 | Dec 2008 | WO |
WO 2008151204 | Dec 2008 | WO |
WO 2009048700 | Apr 2009 | WO |
WO 2009105365 | Aug 2009 | WO |
WO 2009132045 | Oct 2009 | WO |
WO 2009135166 | Nov 2009 | WO |
WO 2010030991 | Mar 2010 | WO |
WO 2011057002 | May 2011 | WO |
WO 2012032030 | Mar 2012 | WO |
WO 2012099704 | Jul 2012 | WO |
WO 2012099909 | Jul 2012 | WO |
WO 2012113554 | Aug 2012 | WO |
WO 2013016618 | Jan 2013 | WO |
WO 2013025711 | Feb 2013 | WO |
WO 2013109309 | Jul 2013 | WO |
2013159065 | Oct 2013 | WO |
WO 2013162817 | Oct 2013 | WO |
WO 2014029835 | Feb 2014 | WO |
WO 2014078286 | May 2014 | WO |
WO 2014110589 | Jul 2014 | WO |
WO 2014137467 | Sep 2014 | WO |
WO 2015073704 | May 2015 | WO |
2015160721 | Oct 2015 | WO |
2015171268 | Nov 2015 | WO |
WO 2015166013 | Nov 2015 | WO |
WO 2015184075 | Dec 2015 | WO |
WO 2015187196 | Dec 2015 | WO |
WO 2016044647 | Mar 2016 | WO |
WO 2016107357 | Jul 2016 | WO |
WO 2016137997 | Sep 2016 | WO |
WO 2017161283 | Sep 2017 | WO |
WO 2018051187 | Mar 2018 | WO |
WO 2019038293 | Feb 2019 | WO |
WO 2012034135 | Mar 2021 | WO |
Entry |
---|
Extended European Search Report dated Jun. 5, 2019 in corresponding European Application No. 19153590.5. |
Extended European Search Report issued in corresponding European Patent Application No. 19 21 5277 dated May 12, 2020. |
Altes et al., Creation of Saccular Aneurysms in the Rabbit: A Model Suitable for Testing Endovascular Devices AJR 2000; 174: 349-354. |
Schaffer, Advanced Materials & Processes, Oct. 2002, pp. 51-54. |
Number | Date | Country | |
---|---|---|---|
20200397447 A1 | Dec 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15879196 | Jan 2018 | US |
Child | 17007272 | US |